Chemoinformaics analysis of 1,2-DIOLEOYL-3-PALMITOYLGLYCEROL
| Molecular Weight | 859.415 | nRot | 49 |
| Heavy Atom Molecular Weight | 756.599 | nRig | 5 |
| Exact Molecular Weight | 858.768 | nRing | 0 |
| Solubility: LogS | -7.981 | nHRing | 0 |
| Solubility: LogP | 17.701 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 163 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 61 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 102 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 55 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 164.675 |
| nHD | 0 | BPOL | 110.139 |
| QED | 0.026 |
| Synth | 3.381 |
| Natural Product Likeliness | 0.389 |
| NR-PPAR-gamma | 0.038 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.041 |
| HIA | 0.005 |
| CACO-2 | -5.216 |
| MDCK | 0.000000968 |
| BBB | 0 |
| PPB | 1.11934 |
| VDSS | 4.356 |
| FU | 0.00426992 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.075 |
| CYP2c19-inh | 0.052 |
| CYP2c19-sub | 0.024 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.989 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.003 |
| CYP3a4-inh | 0.127 |
| CYP3a4-sub | 0.005 |
| CL | 4.617 |
| T12 | 0.006 |
| hERG | 0.191 |
| Ames | 0.003 |
| ROA | 0.001 |
| SkinSen | 0.997 |
| Carcinogencity | 0.056 |
| EI | 0.842 |
| Respiratory | 0.08 |
| NR-Aromatase | 0.04 |
| Antiviral | Yes |
| Prediction | 0.735429 |